tradingkey.logo

Stevanato Group SpA

STVN
查看詳細走勢圖
15.500USD
+1.350+9.54%
收盤 02/06, 16:00美東報價延遲15分鐘
4.23B總市值
35.26本益比TTM

Stevanato Group SpA

15.500
+1.350+9.54%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+9.54%

5天

-0.51%

1月

-28.21%

6月

-35.55%

今年開始到現在

-22.96%

1年

-31.05%

查看詳細走勢圖

TradingKey Stevanato Group SpA股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Stevanato Group SpA當前公司基本面數據相對健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名58/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為28.99。中期看,股價處於下降通道。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Stevanato Group SpA評分

相關信息

行業排名
58 / 205
全市場排名
162 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Stevanato Group SpA亮點

亮點風險
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
高分紅
公司屬於高分紅公司,最新股息支付率12.27%
估值低估
公司最新PE估值35.26,處於3年歷史低位
機構減倉
最新機構持股53.34M股,環比減少22.52%
景順投資公司持倉
明星投資者景順投資公司持倉,最新持倉945.00股

分析師目標

基於 11 分析師
買入
評級
28.993
目標均價
+104.90%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Stevanato Group SpA新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Stevanato Group SpA簡介

Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
公司代碼STVN
公司Stevanato Group SpA
CEOStevanato (Franco)
網址https://www.stevanatogroup.com/
KeyAI